Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Accumulated Depreciation (2019 - 2020)

Pliant Therapeutics (PLRX) has disclosed Accumulated Depreciation for 2 consecutive years, with $3.2 million as the latest value for Q3 2020.

  • On a quarterly basis, Accumulated Depreciation changed N/A to $3.2 million in Q3 2020 year-over-year; TTM through Sep 2020 was $3.2 million, a N/A change, with the full-year FY2019 number at $2.2 million, changed N/A from a year prior.
  • Accumulated Depreciation was $3.2 million for Q3 2020 at Pliant Therapeutics, up from $2.2 million in the prior quarter.
  • In the past five years, Accumulated Depreciation ranged from a high of $3.2 million in Q3 2020 to a low of $2.2 million in Q4 2019.